CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Fresenius is a world leading provider of innovative products and services for dialysis, hospital and outpatient treatment. The company was founded in 1912, first as a pharmaceutical lab, then a small-town manufacturer. Today, Fresenius operates in more than 100 countries.
The Fresenius Group is comprised of four independent business segments: Fresenius Medical Care, a dialysis care company; Fresenius Helios, a private hospital operator; Fresenius Kabi, a drug and clinical nutrition supplier; Fresenius Vamed, a healthcare facilities developer.
Fresenius share price info: Fresenius shares are traded on the stock exchanges in Frankfurt, Munich and Dusseldorf. Regarding market cap, the group belongs to Germany’s 30 major companies. As a top-rated blue chip company, Fresenius is a constituent of the Germany’s DAX index and Europe's EURO STOXX 50.
FRE stock is featured in the following indices: STOXX Europe 600 Health Care, the FTSEurofirst 300, the DAXsector Pharma & Healthcare.
Nvidia (NVDA) is down approximately 27.37% since the beginning of 2025 (as of mid-April), and up 26.48% year on year – based on its $98.78 open price on 22 April 2025.
The US Tech 100 is down approximately 5.08% year on year (as of late April 2025), and 11.21% year to date, based on its 23 April 2025 opening price of $9,201.47.
14:22, 25 April 2025
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements